SCHEMBL28014273

SCHEMBL28014273

O=S(=O)(c1ccc(F)cc1)c1ccc2c(c1)NCCC2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.58
HTR2B P41595 4/20 0.58
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
GFER P55789 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.45
HTR6 P50406 3/20 0.42
PYGL P06737 1/20 0.41
PNMT P11086 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
KMT2A Q03164 1/20 0.40
HTR2A P28223 1/20 0.38
KCNH2 Q12809 1/20 0.38
MAPT P10636 1/20 0.38
ACHE P22303 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
MLNR O43193 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3112268 0.79 PYGL (0.49) HTR2CCA12CA1CA2CA9
SCHEMBL29622425 0.79 PYGL (0.49) HTR2CCA12CA1CA2CA9
SCHEMBL28305388 0.78 CA1 (0.77) CA12CA1CA2CA9GFER
SCHEMBL2404788 0.78 CA12 (0.54) HTR2CHTR2BCA12CA1CA2
SCHEMBL10893085 0.78 CA12 (0.54) HTR2CHTR2BCA12CA1CA2
SCHEMBL17785623 0.78 GFER (0.56) CA12CA1CA2CA9GFER
SCHEMBL1439875 0.78 CA12 (0.54) CA12CA1CA2CA9GFER
Hydrochloric Acid SCHEMBL30142485 0.77 PYGL (0.48) HTR2CCA12CA1CA2CA9
Hydrochloric Acid SCHEMBL2144161 0.77 PYGL (0.48) HTR2CCA12CA1CA2CA9
Methane SCHEMBL8122180 0.77 CA12 (0.53) HTR2CHTR2BCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102883607-B Compounds for the treatment of cancer GTX INC 2015-07-22 CN disclosed
CN-104592205-A COMPOUNDS FOR TREATMENT OF CANCER GTX INC 2015-05-06 CN disclosed